ZA972462B - Purification of plasmid DNA of pharmaceutical quality. - Google Patents

Purification of plasmid DNA of pharmaceutical quality.

Info

Publication number
ZA972462B
ZA972462B ZA9702462A ZA972462A ZA972462B ZA 972462 B ZA972462 B ZA 972462B ZA 9702462 A ZA9702462 A ZA 9702462A ZA 972462 A ZA972462 A ZA 972462A ZA 972462 B ZA972462 B ZA 972462B
Authority
ZA
South Africa
Prior art keywords
purification
plasmid dna
pharmaceutical quality
pharmaceutical
quality
Prior art date
Application number
ZA9702462A
Other languages
English (en)
Inventor
Pierre Wils
Monique Ollivier
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA972462B publication Critical patent/ZA972462B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9702462A 1996-03-21 1997-03-20 Purification of plasmid DNA of pharmaceutical quality. ZA972462B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603519A FR2746412B1 (fr) 1996-03-21 1996-03-21 Purification d'adn plasmidique de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
ZA972462B true ZA972462B (en) 1997-09-29

Family

ID=9490391

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702462A ZA972462B (en) 1996-03-21 1997-03-20 Purification of plasmid DNA of pharmaceutical quality.

Country Status (15)

Country Link
US (1) US6730781B1 (cs)
EP (1) EP0902835A1 (cs)
JP (1) JP2000506736A (cs)
KR (1) KR100502116B1 (cs)
AU (1) AU730755B2 (cs)
BR (1) BR9708227A (cs)
CA (1) CA2249465A1 (cs)
CZ (1) CZ295587B6 (cs)
FR (1) FR2746412B1 (cs)
HU (1) HU225426B1 (cs)
IL (1) IL126268A0 (cs)
NO (1) NO984342L (cs)
SK (1) SK129198A3 (cs)
WO (1) WO1997035002A1 (cs)
ZA (1) ZA972462B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026468B2 (en) 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US6214586B1 (en) * 1997-12-08 2001-04-10 Genzyme Corporation Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA
CZ303086B6 (cs) * 2000-05-26 2012-03-28 Aventis Pharma S.A. Zpusob purifikace dvojretezcové DNA užitím imobilizovaného oligonukleotidu
FR2822476B1 (fr) * 2001-03-23 2004-04-02 Aventis Pharma Sa Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice
WO2002077274A2 (fr) * 2001-03-23 2002-10-03 Gencell S.A. Procedes de purification et de detection de sequences cibles d'adn double brin par interaction triple helice.
EP1554398A4 (en) 2002-09-13 2005-12-14 Valentis Inc DEVICE AND METHOD FOR THE CLEANING OF NUCLEAR SULFUR IN THE PREPARATIVE SCALE
EP1628749B1 (en) 2003-05-30 2019-07-31 VGXI, Inc. Devices and methods for biomaterial production
EP1664277B1 (en) * 2003-09-17 2011-11-09 Aventis Pharma S.A. Method of preparation of pharmaceutically grade plasmid dna
AU2005233309B2 (en) * 2004-04-19 2011-03-31 Centelion Method for purifying plasmid DNA
EP1737945B1 (en) * 2004-04-19 2011-01-26 Aventis Pharma S.A. Method for purifying plasmid dna
AU2005280356B2 (en) 2004-08-16 2008-09-25 Clague P. Hodgson Improved strains of E. coli for plasmid DNA production
CN101443452B (zh) 2004-11-30 2013-03-27 梅瑞尔有限公司 用于细胞化学裂解的混合装置
US20120258502A1 (en) * 2011-04-08 2012-10-11 Vinod Pandiripally Method of producing recombinant plasmid dna using substantially solid growth medium
US20120283503A1 (en) * 2011-04-29 2012-11-08 The Johns Hopkins University Nanoparticle loaded stem cells and their use in mri guided hyperthermia
CN116790578B (zh) * 2023-08-22 2023-12-12 赛奥斯博生物科技(北京)有限公司 一种基于碱裂解法快速纯化质粒的生产工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2691586B2 (ja) * 1987-10-22 1997-12-17 旭光学工業株式会社 多孔質セラミックス及びその製法
JPH01135792A (ja) * 1987-11-20 1989-05-29 Mitsui Toatsu Chem Inc 核酸の分離・精製方法
CA2006008C (en) * 1988-12-20 2000-02-15 Donald J. Kessler Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
JPH08505534A (ja) * 1993-01-13 1996-06-18 森永乳業株式会社 Ｍ−ｃｓｆ２２３の製造方法
US5503816A (en) * 1993-09-27 1996-04-02 Becton Dickinson And Company Silicate compounds for DNA purification
DE59507433D1 (de) * 1994-02-07 2000-01-20 Qiagen Gmbh Verfahren zur herstellung endotoxinfreier oder an endotoxin abgereicherter nucleinsäuren und/oder oligonucleotide für die gentherapie
US5576196A (en) * 1995-01-13 1996-11-19 Vical Incorporated Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
ATE238321T1 (de) 1996-02-06 2003-05-15 Roche Diagnostics Gmbh Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung

Also Published As

Publication number Publication date
JP2000506736A (ja) 2000-06-06
HUP9902152A3 (en) 2001-04-28
IL126268A0 (en) 1999-05-09
HUP9902152A2 (hu) 1999-11-29
NO984342D0 (no) 1998-09-18
AU2166197A (en) 1997-10-10
CZ295587B6 (cs) 2005-08-17
NO984342L (no) 1998-09-18
BR9708227A (pt) 1999-07-27
US6730781B1 (en) 2004-05-04
CA2249465A1 (fr) 1997-09-25
KR20000064693A (ko) 2000-11-06
WO1997035002A1 (fr) 1997-09-25
EP0902835A1 (fr) 1999-03-24
FR2746412A1 (fr) 1997-09-26
CZ298498A3 (cs) 1999-01-13
AU730755B2 (en) 2001-03-15
KR100502116B1 (ko) 2005-12-20
HU225426B1 (en) 2006-11-28
FR2746412B1 (fr) 1998-06-12
SK129198A3 (en) 1999-03-12

Similar Documents

Publication Publication Date Title
AU3672797A (en) Affinity-based purification of oligonucleotides using soluble multimeric oligonucleotides
ZA979996B (en) Protein purification
AU4787697A (en) Therapeutic gene
IL122528A0 (en) Catalytic dna
AU4391897A (en) Method of sequencing dna
GB9620769D0 (en) Nucleic acid sequencing
ZA972462B (en) Purification of plasmid DNA of pharmaceutical quality.
HU9600235D0 (en) Dna sequencing enzymes
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
GB9600384D0 (en) Dna glycosylases
GB9607066D0 (en) Purification process
AU3737297A (en) Bacteriophage-mediated gene therapy
AU2317095A (en) Dna sequences
ZA973642B (en) DNA vaccine formulations.
AUPO761697A0 (en) Process for the purification of polyethers
FR2753204B1 (fr) Procede de preparation d'adn plasmidique
AU6614198A (en) Purification process
GB9502468D0 (en) DNA Sequence
AU6525298A (en) Process for purifying caprolactam
HUP9900317A3 (en) Pharmaceutical composition useful for nucleic acid transfection, and use thereof
AU4041997A (en) Dna purification procedure
AU4425397A (en) Antisense gene therapy for rna viruses
IL128351A0 (en) Pharmaceutical composition for treating viral diseases
GB9608376D0 (en) Spinal column separation
EP0801526A4 (en) GENE TRANSDUCTION SYSTEM